News
KA
0.6420
-5.59%
-0.0380
Weekly Report: what happened at KA last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at KA last week (0708-0712)?
Weekly Report · 07/15 12:04
Weekly Report: what happened at KA last week (0701-0705)?
Weekly Report · 07/08 12:06
TuHURA Biosciences And Kintara Therapeutics Announce Agreement For Potential Acquisition Of Kineta's Anti-VISTA Antibody
KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor. The drug is currently in a Phase 1/Phase 2 clinical study in patients with advanced solid tumors. KVA12 123 has demonstrated a favorable clinical safety and tolerability profile. $5 million investment from existing TuHURA shareholder.
Benzinga · 07/08 10:35
KINETA ANNOUNCES EXCLUSIVITY AND RIGHT OF FIRST OFFER AGREEMENT FOR ITS VISTA BLOCKING ANTIBODY WITH TUHURA BIOSCIENCES
Reuters · 07/08 10:30
KINETA INC: KINETA WILL RECEIVE A $5 MLN NONREFUNDABLE PAYMENT FROM TUHURA
Reuters · 07/08 10:30
Weekly Report: what happened at KA last week (0624-0628)?
Weekly Report · 07/01 12:07
Weekly Report: what happened at KA last week (0617-0621)?
Weekly Report · 06/24 12:17
12 Health Care Stocks Moving In Thursday's After-Market Session
Psyence Biomedical stock moved upwards by 68.1% to $1.0 during Thursday's after-market session. Kintara Therapeutics (NASDAQ:KTRA) shares rose by 15.67% during the session. Clover Health Investments and Helius Medical Tech were among the day's gainers.
Benzinga · 06/20 20:31
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
NLS Pharmaceutics (NASDAQ:NLSP) stock is rocketing more than 156% alongside heavy pre-market trading. Actelis Networks shares are soaring over 137% after announcing a new partnership with Carahsoft. Biggest Pre-Market Stock Movers: 10 Top Gainers and 10 Top Losers for Tuesday.
Investorplace · 06/18 11:37
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Nurix Therapeutics, Inc. Rose sharply in today's pre-market trading. The company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia. Nurix shares jumped 12.1% to $17.01 in the pre-markets trading session. Scinai Immunotherapeutics Ltd. And The Aaron's Company were among the stocks moving in pre- market trading.
Benzinga · 06/17 12:43
12 Health Care Stocks Moving In Monday's Pre-Market Session
Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 77.4% to $6.19 during Monday's pre-market session. ENDRA Life Sciences and Venus Concept stock also moved upwards. Ovid Therapeutics stock declined by 63.5% during the session.
Benzinga · 06/17 12:07
Weekly Report: what happened at KA last week (0610-0614)?
Weekly Report · 06/17 12:05
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Biggest pre-market stock movers: Scinai Immunotherapeutics (NASDAQ:SCNI) stock is rocketing more than 69% with heavy pre- market trading. 10 top losers: Kaival Brands Innovations stock is plummeting over 35% after a massive rally on Friday. A clinical trial news, a private offering and more are moving stocks this morning.
Investorplace · 06/17 11:40
Weekly Report: what happened at KA last week (0603-0607)?
Weekly Report · 06/10 12:09
12 Health Care Stocks Moving In Thursday's Intraday Session
Virax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. American Oncology Network stock rose 32.96% during the session. Ventyx Biosciences stock fell 37.9% in the same session.
Benzinga · 06/06 16:31
12 Health Care Stocks Moving In Wednesday's Intraday Session
EndRA Life Sciences (NASDAQ:NDRA) stock increased by 79.2% to $0.15 during Wednesday's regular session. Rezolute stock moved upwards by 23.91% and Bright Green shares rose 23.07%. SILO Pharma stock decreased by 36.5% during the regular session to $1.43.
Benzinga · 06/05 16:31
Weekly Report: what happened at KA last week (0527-0531)?
Weekly Report · 06/03 12:12
KINETA INC: ON MAY 23, GOT NOTICE FROM NASDAQ THAT IT NO LONGER COMPLIES WITH REQUIREMENT UNDER NASDAQ LISTING RULE 5550(B)(1)
Reuters · 05/30 20:20
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by to $ during Wednesday's pre-market session. The company's, Q1 earnings came out yesterday. Surmodics, Ikena Oncology and Genetic Technologies also moved upwards. Losers include Cue Health and Biohaven.
Benzinga · 05/29 12:06
More
Webull provides a variety of real-time KA stock news. You can receive the latest news about KINETA INC through multiple platforms. This information may help you make smarter investment decisions.
About KA
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a monoclonal antibody (mAb), immunotherapy targeting VISTA (V-domain Ig suppressor of T cell activation), and an anti-CD27 agonist mAb immunotherapy. KVA12123 may be an effective immunotherapy for many types of cancer, including non-small cell lung cancer (NSCLC), colorectal cancer (CRC), ovarian cancer (OC), renal cell carcinoma (RCC) and head and neck squamous cell carcinoma. It is also developing an anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The nominated lead candidate is a fully human mAb that demonstrates nanomolar (nM) binding affinity to CD27 in humans.